PHS
AGN.PRA

PFM Health Sciences’s Allergan plc AGN.PRA Stock Holding History

PFM Health Sciences’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-107,410
Closed -$79.2M – 109
2017
Q3 		$79.2M Buy
+107,410
New +$89.2M 1.56% 21

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PFM Health Sciences's AGN.PRA Position: Q4 2017 in Review

PFM Health Sciences sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 107,410 shares — an estimated $79.2M sold.

PFM Health Sciences first reported a position in AGN.PRA in Q3 2017 and held it in 1 quarter. The position peaked at $79.2M in Q3 2017. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • PFM Health Sciences reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • PFM Health Sciences sold 107,410 Allergan plc shares in Q4 2017, an estimated $79.2M.
  • PFM Health Sciences first reported a position in Allergan plc in Q3 2017 and held it in 1 quarter.
  • PFM Health Sciences's Allergan plc position peaked at $79.2M in Q3 2017.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.